The Salmonella testing market is estimated to be valued at US$ 2.91 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The Salmonella testing market involves detection and identification of Salmonella bacteria that causes food poisoning. The key products in the market are assays, kits and reagents that are used to test food samples, clinical samples and environmental samples for the presence of Salmonella. Major end-users include food processing companies, pharmaceutical companies, clinical laboratories and research institutions.
Market Dynamics:
Rising global outbreaks of foodborne illnesses caused by Salmonella infection is a major factor driving growth of the Salmonella testing market. According to WHO, non-typhoidal Salmonella causes over 90 million cases of gastroenteritis each year globally. Growing consumer awareness about food safety and stringent regulations mandating Salmonella testing of various food products is also fueling adoption of rapid testing methods. Technological advancements introducing portable and microfluidic devices for onsite and point-of-care Salmonella detection present lucrative growth opportunities. Moreover, expanding applications of Salmonella testing from food to pharmaceutical, clinical and environmental sample analysis would further propel the market growth over the forecast period.
SWOT Analysis
Strength: Salmonella testing market is growing rapidly due to increasing incidence of salmonellosis across the globe. Presence of advanced and accurate testing kits and services allows early detection of salmonella. Rising awareness regarding food safety and quality is driving the market.
Weakness: High cost associated with advanced testing technologies limits its adoption in underdeveloped regions. Lack of infrastructure and skilled professionals poses challenge, especially in low and middle income countries.
Opportunity: Growing food industry in developing nations along with favorable government initiatives for food safety creates lucrative opportunities. Rapid advancement in technologies such as PCR, immunoassays offers scope to develop improved test kits.
Threats: Changing regulatory landscape and stringent approvals delay product launch. Differences in food safety standards across countries act as a barrier. Emergence of alternative technologies poses threat.
Key Takeaways
The Global Salmonella Testing Market is expected to witness high growth, exhibiting CAGR of 7.8% over the forecast period, due to increasing foodborne illnesses worldwide. According to CDC, salmonellosis causes around 1.35 million infections annually in the U.S.
Regional analysis: North America dominates the global market owing to stringent food safety regulations and major presence of key players. Asia Pacific exhibits fastest growth due to rising awareness, improving healthcare infrastructure and expanding food industry in countries like China and India.
Key players operating in the Salmonella Testing market are Thermo Fisher Scientific, Merck KGaA, bioMérieux SA, Neogen Corporation, QIAGEN N.V., 3M Company, PerkinElmer Inc., Romer Labs Division Holding GmbH, Eurofins Scientific, Hardy Diagnostics, Charles River Laboratories International Inc., LabCorp, R-Biopharm AG, Biomerica Inc., Zeulab S.L.
Popular Posts
